In the course of carrying out their daily functions, pharmacists can identify trends in inhaler use or refills, new medications, and gaps in patient education. Results from a pooled posthoc analysis of the pivotal NAVIGATOR Phase III and PATHWAY Phase IIb trials showed AstraZeneca and Amgen’sTezspire demonstrated reductions in the annualized asthma exacerbation rate across biomarker subgroups of patients with severe asthma. The COVID-19 pandemic has laid bare disparities in global healthcare and, as a result, has helped broaden the understanding of health equity in the life sciences industry beyond just racial diversity. Although much of the renewed attention towards diversity and inclusion has centered around clinical trials, advertising and marketing efforts have also been revamped to address cultural equity — and for good reasons. Tezspire is FDA-approved as an add-on maintenance treatment for severe asthma in children ages 12 years and older. Tezspire and Dupixent are add-on maintenance (long-term) treatments for severe asthma.

Tezspire is a long-term treatment for severe asthma that can reduce your asthma symptoms and help prevent asthma attacks. Tezspire is FDA-approved as an add-on maintenance (long-term) treatment for severe asthma in adults and children ages 12 years and older. In some cases, your doctor may recommend stopping certain other asthma medications if your asthma improves with Tezspire. But you should not make any changes to your asthma treatment, especially any corticosteroids you take, without discussing it with your doctor first. Stopping your other asthma treatments or reducing your doses could make your asthma worse.

Will I Still Have To Take My Other Asthma Medications Daily With Tezspire?

AstraZeneca manufactures TEZSPIRE and provided sponsorship/funding for the studies discussed. Some authors may have a financial interest in either TEZSPIRE or AstraZeneca and may have received compensation in connection with these studies or other engagements. TEZSPIRE helps prevent severe tezspire together asthma attacks and can improve your breathing. In a pre-specified exploratory analysis from NAVIGATOR, Tezspire demonstrated consistent efficacy throughout the year regardless of the season. Data show that Tezspire reduced the AAER by 63% , 46% , 62% and 54% , compared to placebo.

Even when clinical trials are successful, regulatory authorities may question the sufficiency for approval of the trial endpoints Amgen has selected. Amgen develops product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as Amgen may have believed at the time of entering into such relationship.

• TEZSPIRE should not be used to treat acute asthma symptoms, acute exacerbations, acute bronchospasm, or status asthmaticus.
• Eligibility is based on Federal Poverty Level.Program also offers co-pay assistance.
• Asthma exacerbations were defined as the use or an increased dose of systemtic glucocosteroids, an emergency department visit because of asthma or an asthma-related inpatient hospitalization.
• Tezepelumab may also be used for purposes not listed in this medication guide.
• Point32Health is the parent organization of Harvard Pilgrim Health Care and Tufts Health Plan.
• Adding plans allows you to compare formulary status to other drugs in the same class.

Pharmacists can play a crucial role in educating patients, assessing their symptom control, and counseling them on nonpharmacologic interventions. Three MABs targeting IL-5 treat uncontrolled severe asthma in GINA steps 4 and 5. Potential predictors of a positive response to these medications are higher blood eosinophils, increased frequency of severe exacerbations in the past year, adult-onset asthma, nasal polyps, baseline maintenance OCS, and poor lung function. It is important to be aware that maintenance https://xcritical.com/ and reliever therapy with low-dose ICS-formoterol is recommended in the track 1 approach for adults and adolescents. MART was found to reduce the risk of exacerbations with similar or better symptom control compared with the combination of maintenance inhaler plus SABA.¹ Refer to FIGURES 1–3 for a detailed overview of asthma management for steps 1 through 5. “Tezspire represents a much-needed new treatment for the many patients who remain underserved and continue to struggle with severe, uncontrolled asthma.”

In July 2021, TEZSPIRE was the first and only biologic to be granted Priority Reviewin the U.S. for the treatment of asthma by the FDA. “Severe asthma has historically been a complex disease for patients to manage and for physicians to treat,” said Murdo Gordon, executive vice president of Global Commercial Operations at Amgen. As an add-on maintenance therapy for severe asthma in adults and children 12 years or older, and received FDA approval for the therapy in late 2021.

To help make sure that you don’t miss an appointment to have Tezspire, be sure to put your treatment schedule on your calendar. Administration of Tezspire is carried out by your healthcare professional in their office or clinic. You’ll receive Tezspire as a subcutaneous injection in your upper arm, thigh, or abdomen . Talk with your doctor if you have questions about taking other asthma medications in combination with Tezspire.

What Is The Most Important Information I Should Know About Tezepelumab?

Completing the CAPTCHA proves you are a human and gives you temporary access to the web property. It’s not known if it’s safe to breastfeed during treatment with Tezspire. For more information, see the “Tezspire and breastfeeding” section above.

Tezepelumab is injected under the skin, usually once every 4 weeks. In 2020, AstraZeneca and Amgen updated a 2012 collaboration agreement for TEZSPIRE. Both companies will continue to share costs and profits equally after payment by AstraZeneca of a mid single-digit inventor royalty to Amgen. AstraZeneca continues to lead development and Amgen continues to lead manufacturing. All aspects of the collaboration are under the oversight of joint governing bodies. Under the amended agreement, AstraZeneca and Amgen will jointly commercialize TEZSPIRE in North America.

You may report side effects related to AstraZeneca products by clicking here. Is greater during the third trimester of pregnancy; therefore, potential effects on a fetus are likely to be greater during the third trimester of pregnancy. The concomitant use of TEZSPIRE and live attenuated vaccines has not been evaluated. The use of live attenuated vaccines should be avoided in patients receiving TEZSPIRE. #Nurse educators are nurses by training, but they are not part of your treatment team or an extension of your doctor’s office. ¶Nurse educators are nurses by training, but they are not part of your treatment team or an extension of your doctor’s office.

Fda Approves Tezspire Tezepelumab

If you have a sudden asthma flare-up, you should use your rescue medication as prescribed by your doctor. See your doctor if your asthma symptoms don’t improve or get worse after starting Tezspire. To help make sure that you don’t miss an appointment to have your dose of Tezspire, be sure to put your treatment schedule on your calendar. You could also try using a medication reminder or download a reminder app on your phone. Tezspire works by blocking a protein that’s involved in airway inflammation, called thymic stromal lymphopoietin. It’s the first drug that works in this way to receive FDA approval.

For instance, the drugmakers know that patients often check weather apps for information on pollen counts and humidity levels and is seeking to reach them in those moments. The computer-generated animation style is designed to stand out visually from other advertisements to grab viewers’ attention, Chevlen says. Ads for the campaign appear on television, streaming and digital devices — including on weather, gaming, and social media platforms like TikTok — as part of a “360-degree ecosystem… that integrates key tactics like personalized content marketing,” she adds. “The unique characters in the ‘Be You’ campaign were created to drive audiences to question their own biases and preconceptions to promote inclusivity. It’s important for patients to feel empowered and understand that their asthma doesn’t make them an outcast,” she suggests. AstraZeneca aims to reach 95% of lupus patients with the campaign by the end of the year and is seeking to reach patients on channels they’re already on with video and social media ads.

Free7 Day Trial Access

African American people have a higher risk of severe asthma symptoms than some other racial groups, such as white American people. Tezspire is a maintenance (long-term) treatment that helps prevent asthma flare-ups. It’s used as an add-on treatment, which means you’ll receive it in combination with your current asthma medications. Tezspire contains the active drug tezepelumab-ekko, while Dupixent contains the active drug dupilumab. And monoclonal antibodies block the activity of certain proteins in the body. But Tezspire and Dupixent block different proteins involved in causing inflammation.

Getting Back To Being You With Severe Asthma Doesn’t Mean Going It Alone Lets Do This Together

With severe asthma, standard asthma medications may not work well for you. So you may still have frequent asthma symptoms and asthma attacks even with treatment. Reeducation upon changes in treatment is imperative to successful therapy. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. As accessible HCPs, they have a unique opportunity to identify and prevent inadequate asthma control.

Alternatives For Severe Asthma

Tezspireis not indicated for the relief of acute bronchospasm or status asthmaticus. The most common adverse reactions (incidence ≥3%) are pharyngitis, arthralgia, and back pain. TEZSPIRE is not indicated for the relief of acute bronchospasm or status asthmaticus. Talk to your healthcare provider about the best way to feed your baby if you use TEZSPIRE.

Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico, and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products.

“For the first time, many people living with severe asthma have the opportunity to receive treatment regardless of the cause of their inflammation.” In a mechanistic study ,9 airway hyperresponsiveness to mannitol, an exploratory outcome, was reduced in patients treated with TEZSPIRE 210 mg Q4W + SOC and placebo + SOC. There was a numerically greater reduction in AHR to mannitol in patients who received TEZSPIRE compared with those who received placebo, both in terms of absolute PD15 and in doubling doses. The clinical significance of this outcome and its impact on asthma have not been established.